CYCC icon

Cyclacel Pharmaceuticals
CYCC

Overview Fund Activity

1 hedge funds and large institutions have $1.3M invested in Cyclacel Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

Holders
1
Holders Change
-1
Holders Change %
-50%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

1
Allianz Asset Management
1
Allianz Asset Management
Germany
$0
2
Goldman Sachs
2
Goldman Sachs
New York
$102K
3
IPC
3
Invesco Private Capital
New York
$41K
4
California Public Employees Retirement System
4
California Public Employees Retirement System
California
$56K
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$60K
Name Holding Trade Value Shares
Change 		Shares
Change %
ICAS
26
Investors Capital Advisory Services
Massachusetts
– -$33K – –
RCM
27
Rotella Capital Management
Washington
– -$67K – –
TRCT
28
Tower Research Capital (TRC)
New York
– -$1K – –
Jane Street
29
Jane Street
New York
– -$41K – –
Susquehanna International Group
30
Susquehanna International Group
Pennsylvania
– -$59K – –
Wells Fargo
31
Wells Fargo
California
– -$30K – –
1
2